The economic case for faecal occult blood screening [4]

Annals of Oncology

Volumn 13, Issue 12, 2002, Pages 1953-1955

  Whynes, David K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; CLINICAL PROTOCOL; COLON RADIOGRAPHY; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; LETTER; MATHEMATICAL MODEL; OCCULT BLOOD TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RESOURCE MANAGEMENT; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY; SYMPTOMATOLOGY;

COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 0036928519     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf344     Document Type: Letter

References (21)

1. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371.
2. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477.
3. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471.
4. Walker AR, Whynes DK, Hardcastle JD, Chamberlain JO. The hospital costs of diagnostic procedures for colorectal cancer. J Clin Epidermiol 1991; 44: 907-914.
5. Whynes DK, Walker AR, Chamberlain JO, Hardcastle JD. Screening and the costs of treating colorectal cancer. Br J Cancer 1993; 68: 965-968.
6. Walker AR, Whynes DK, Chamberlain JO, Hardcastle JD. The cost of screening for colorectal cancer. J Epidemiol Community Health 1991; 45: 220-224.
7. Walker A, Whynes DK. Filtering strategies in mass population screening for colorectal cancer: an economic evaluation. Med Decis Making 1992; 12: 2-7.
8. Whynes DK, Walker AR, Hardcastle JD. Cost-effective screening strategies for colorectal. cancer. J Public Health Med 1992; 14: 43-49.
9. Walker AR, Whynes DK, Hardcastle JD. Rehydration of guaiac-based faecal occult blood tests in mass screening for colorectal cancer: an economic perspective. Scand J Gastroenterol 1991; 26: 215-218.
10. Whynes DK, Neilson AR, Robinson M, Hardcastle JD. Colorectal cancer screening and quality of life. Qual Life Res 1994; 3: 191-198.
11. Neilson AR, Whynes DK. Cost-effectiveness of screening for colorectal cancer: a simulation model. IMA J Math Appl Med Biol 1995; 12: 355-367.
12. Whynes DK, Neilson AR, Walker AR, Hardcastle JD. Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ 1998; 7: 21-29.
13. Whynes DK. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial. Crit Rev Oncol Hematol 1999; 32: 155-165.
14. Gyrd-Hansen D, Sogaard J, Kronborg O. Colorectal cancer screening: efficiency and effectiveness. Health Econ 1998; 7: 9-20.
15. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 1954-1961.
16. Khandker RK, Dulski JD, Kilpatrick JB et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 2000; 16: 799-810.
17. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133: 573-594.
18. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? a comparison of costs, effectiveness and compliance. Am J Med 2001; 111: 593-601.
19. Woolf SH. The best screening test for colorectal cancer-a personal choice. N Engl J Med 2000; 343: 1641-1643.
20. UK Flexible Sigmoidoscopy Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre trial. Lancet 2002; 359: 1291-1300.
21. Geul KW, Bosman FT, van Blankenstein M et al. Prevention of colorectal cancer: costs and effectiveness of sigmoidoscopy. Scand J Gastroenterol Suppl 1997; 223: 79-87.